| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/28/2007 | WO2007022938A3 Compounds |
| 06/28/2007 | WO2007007905A3 Carboxamide compound and use of the same |
| 06/28/2007 | WO2004000210A3 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 06/28/2007 | US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 06/28/2007 | US20070149603 Ppar active compounds |
| 06/28/2007 | US20070149598 M3 muscarinic acetylcholine receptor antagonists |
| 06/28/2007 | US20070149596 Pyrrole derivatives, their preparation and their therapeutic use |
| 06/28/2007 | US20070149594 N-methyl-4-{4-[5-(4-chloro-3-trifluoromethylphenylcarbamoyl)-1H-pyrrol-3-yl]-phenoxy}pyridine-2-carboxamide; Raf kinases inhibitors |
| 06/28/2007 | US20070149589 Process for the Preparation of 4-(benzimidazolylmethylamino)benzamidines |
| 06/28/2007 | US20070149575 5-Aminoalkylpyrazole derivatives as pesticidal agents |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149568 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 06/28/2007 | US20070149566 e.g. 4-({(E)-4-[(2-carboxy-6-fluoro-4-quinolinyl)oxy]-2-butenyl}oxy)-6-fluoroquinoline-2-carboxylic acid; antidiabetic, hypoglycemic agent; type II diabetes, dyslipidaemia, obesity, arterial hypertension, atherosclerosis, microangiopathy, macroangiopathy, retinopathy, neuropathy or hyperglycaemia |
| 06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070149551 crop protection agents for controlling harmful fungi; improved activity; [6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-tri-fluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber |
| 06/28/2007 | US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use |
| 06/28/2007 | US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 06/28/2007 | US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents |
| 06/28/2007 | US20070149541 Imidazole compounds |
| 06/28/2007 | US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative |
| 06/28/2007 | US20070149531 Antiviral agents |
| 06/28/2007 | US20070149530 Antiviral agents |
| 06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 06/28/2007 | US20070149512 N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions |
| 06/28/2007 | US20070149503 Anti-migraine spirocycles |
| 06/28/2007 | US20070149502 Spirocyclic anti-migraine compounds |
| 06/28/2007 | US20070149406 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives |
| 06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070148652 Reagent for detecting an analyte |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE102006047988A1 Salz einer Carbonsäure, welche einen N-substituierten Succinimidthiorest enthält, und nicht vulkanisierte Kautschukzusammensetzung, welche dieses enthält Salt of a carboxylic acid containing an N-substituted Succinimidthiorest, and non-vulcanized rubber composition which contains this |
| 06/28/2007 | DE102005061624A1 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen An improved process for the preparation of salts of 4- (Benzimidazolylmethylamino) -Benzamidinen |
| 06/28/2007 | DE102005061623A1 Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen An improved process for preparing 4- (Benzimidazolylmethylamino) -Benzamidinen and salts thereof |
| 06/28/2007 | CA2634804A1 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/28/2007 | CA2634491A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | CA2634391A1 3- (4-{ ¬4-(4-{ ¬3-(3, 3-dimethyl-1-piperidinyl) propyl| 0xy} phenyl) -1-piperidinyl| carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 06/28/2007 | CA2634305A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 06/28/2007 | CA2634172A1 Piperidine derivatives |
| 06/28/2007 | CA2634047A1 Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| 06/28/2007 | CA2633457A1 Heterocyclic amide derivatives as calcium channel blockers |
| 06/28/2007 | CA2633351A1 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors |
| 06/28/2007 | CA2633207A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | CA2633181A1 Salt and polymorph of dpp-iv inhibitor |
| 06/28/2007 | CA2633101A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 06/28/2007 | CA2632936A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | CA2632929A1 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 06/28/2007 | CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs |
| 06/28/2007 | CA2632021A1 Gaba-b receptor modulators |
| 06/28/2007 | CA2631832A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 06/28/2007 | CA2631816A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 06/28/2007 | CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | CA2629991A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | CA2626764A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 06/27/2007 | EP1801110A1 Esomeprazole arginine salt |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1799671A2 Chemical compounds |
| 06/27/2007 | EP1799670A1 Benzoimidazole derivatives useful as antiproliferative agents |
| 06/27/2007 | EP1799669A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 06/27/2007 | EP1799668A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 06/27/2007 | EP1799667A1 Heterocyclic derivatives and their use as therapeutic agents |
| 06/27/2007 | EP1799666A2 Piperidine derivatives as nk1 antagonists |
| 06/27/2007 | EP1799651A2 Small molecule modulators of cytokine activity |
| 06/27/2007 | EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers |
| 06/27/2007 | EP1799649A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 06/27/2007 | EP1799648A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 06/27/2007 | EP1799647A1 Alkil-pyridines as 11-beta inhibitors for diabetes |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 06/27/2007 | EP1799206A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/27/2007 | EP1740574B1 4-amino-5-cyanopyrimidine derivatives |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1140873B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/27/2007 | CN1989129A A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate salt |
| 06/27/2007 | CN1989128A New 4-benzylidene-piperidin derivatives |
| 06/27/2007 | CN1989127A Kynurenic acid amide derivatives as NR2B receptor antagonists |
| 06/27/2007 | CN1989126A 新的杂环羧酸酰胺衍生物 The new heterocyclic carboxylic acid amide derivatives |
| 06/27/2007 | CN1989125A 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi |
| 06/27/2007 | CN1989124A Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 06/27/2007 | CN1989119A 新的苯甲酰脲衍生物 The new benzoyl urea derivatives |
| 06/27/2007 | CN1989113A 喹唑啉衍生物 Quinazoline derivatives |
| 06/27/2007 | CN1989107A 吡啶衍生物 Pyridine derivatives |
| 06/27/2007 | CN1989106A N－羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
| 06/27/2007 | CN1989104A Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 06/27/2007 | CN1989103A Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 06/27/2007 | CN1988907A Dual small molecule inhibitors of cancer and angiogenesis |
| 06/27/2007 | CN1988905A Aryl-pyridine derivatives |
| 06/27/2007 | CN1323079C Renin inhibitors |
| 06/26/2007 | USRE39708 Estrogen receptor modulators |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235656 Anxiolytic agents with reduced sedative and ataxic effects |
| 06/26/2007 | US7235581 For therapy of Alzheimer's disease |
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235578 Used as cytotoxins for cancer therapy and as prodrugs for gene-directed enzyme-prodrug therapy and antibody-directed enzyme-prodrug theraphy |
| 06/26/2007 | US7235576 Inorganic or organic acid salts or basic salts of sorafenib; e.g. sorafenib tosylate; cancer of the lung, pancreas, thyroid, bladder or colon |